Leukemia inhibitory factor induces neurotransmitter switching in transgenic mice.
AUTOR(ES)
Bamber, B A
RESUMO
Leukemia inhibitory factor (LIF) is a cytokine growth factor that induces rat sympathetic neurons to switch their neurotransmitter phenotype from noradrenergic to cholinergic in vitro. To test whether LIF can influence neuronal differentiation in vivo, we generated transgenic mice that expressed LIF in pancreatic islets under the control of the insulin promoter and evaluated the neurotransmitter phenotype of the pancreatic sympathetic innervation. We also used the insulin promoter to coexpress nerve growth factor in the islets, which greatly increased the density of sympathetic innervation and facilitated analysis of the effects of LIF. Our data demonstrate that tyrosine hydroxylase and catecholamines declined and choline acetyltransferase increased in response to LIF. We conclude that LIF can induce neurotransmitter switching of sympathetic neurons in vivo.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=44499Documentos Relacionados
- Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.
- Reduced sympathetic innervation after alteration of target cell neurotransmitter phenotype in transgenic mice.
- A bcr-v-abl oncogene induces lymphomas in transgenic mice.
- Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice.
- Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.
